Showing results (71-80 of 297) with videos related to
Sort By:
Pageof 30
Gynecologic Oncology|February 27, 2004
Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion gradeGernot Hudelist, Mahmood Manavi, Kerstin I D Pischinger, et al.Breast Care (Basel, Switzerland)|December 14, 2017
Influence of Orally Administered Probiotic Lactobacillus Strains on Vaginal Microbiota in Women with Breast Cancer during Chemotherapy: A Randomized Placebo-Controlled Double-Blinded Pilot StudyJulian Marschalek, Alex Farr, Marie-Louise Marschalek, et al.Wiener Klinische Wochenschrift|March 18, 2026
Austrian treatment algorithms 2025: CDK 4/6 inhibitors in the adjuvant therapy of HR+/HER2- early breast cancerRupert Bartsch, Clemens Dormann, Daniel Egle, et al.Radiology|February 16, 2021
Tissue Sodium Concentration Quantification at 7.0-T MRI as an Early Marker for Chemotherapy Response in Breast Cancer: A Feasibility StudyOlgica Zaric, Alex Farr, Lenka Minarikova, et al.Breast Cancer Research and Treatment|November 30, 2004
Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissueGernot Hudelist, Margit Pacher-Zavisin, Christian F Singer, et al.Magnetic Resonance Imaging|March 19, 2019
7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancerOlgica Zaric, Alex Farr, Esau Poblador Rodriguez, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 30, 2014
Histopathological characterization of ulcerated breast cancer and comparison to their non-ulcerated counterpartsChristine Staudigl, Michaela Bartova, Mohamed Salama, et al.Journal of Cancer Research and Clinical Oncology|May 22, 2013
Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutationsAnne Catharina Dressler, Gernot Hudelist, Anneliese Fink-Retter, et al.International Journal of Cancer|December 7, 2013
High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic settingEva-Maria Fuchs, Wolfgang J Köstler, Reinhard Horvat, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 16, 2013
Is breast cancer in young Asian women more aggressive than in Caucasians? A cross-sectional analysisMuy-Kheng M Tea, Lei Fan, James W Delancey, et al.Pageof 30